Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Organisation › Details

Iktos SAS

Iktos is a French start-up specializing in the development of artificial intelligence (AI) solutions applied to chemical research, more specifically to medicinal chemistry and new drug design. Iktos develops a proprietary and innovative solution based on generative deep learning models, which allows, from existing data, to design optimized molecules in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology platform enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as professional services and as a SaaS software platform, Makya™. Iktos also develops Spaya™, a synthesis planning software based on Iktos' proprietary AI technology for retrosynthesis. Iktos has already validated its technology through more than 50 collaborations with pharmaceutical and biotech companies such as Chiesi Group, Galapagos, Janssen, Merck, Teijin, Ono Pharmaceuticals, Pfizer, Servier, UCB... *


Period Start 2016-10-01 established
Products Industry artificial intelligence (AI) / machine learning (ML)
  Industry 2 Makya™ drug discovery SaaS
Person Person Gaston-Mathé, Yann (Iktos 201904 CEO + Co-Founder)
Region Region Paris
  Country France
  Street 65 rue de Prony
  City 75017 Paris
  Tel +33-6-3007-9926
    Address record changed: 2024-01-05
Basic data Employees n. a.
    * Document for »About Section«: Iktos SAS. (3/9/23). "Press Release: Iktos Raises € 15.5m Series A Round to Expand Its Artificial Intelligence-based Drug Discovery Technologies and Solutions". Paris & Lausanne.
Record changed: 2024-03-30


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for Iktos SAS

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top